SCHEMBL927561

SCHEMBL927561

CN(C)C(=O)Cc1ccc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MMP8 P22894 6/20 0.42
MMP3 P08254 3/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
CASP3 P42574 1/20 0.39
RAB9A P51151 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
MAPT P10636 1/20 0.39
GPR35 Q9HC97 1/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
PTGER3 P43115 1/20 0.37
GLA P06280 1/20 0.37
PKM P14618 1/20 0.37
HTT P42858 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926278 0.91 MMP8 (0.44) ALDH1A1NPSR1MMP8MMP3LMNA
SCHEMBL926649 0.91 MMP8 (0.44) ALDH1A1NPSR1MMP8MMP3LMNA
SCHEMBL927615 0.89 GPR35 (0.42) ALDH1A1NPSR1MMP8MMP3LMNA
SCHEMBL926562 0.89 NPC1 (0.50) ALDH1A1NPSR1MMP8MMP3LMNA
SCHEMBL927317 0.86 NPC1 (0.48) ALDH1A1NPSR1MMP8MMP3LMNA
SCHEMBL927537 0.83 MMP8 (0.44) ALDH1A1NPSR1MMP8MMP3MAPT
SCHEMBL929036 0.82 ALDH1A1 (0.44) ALDH1A1NPSR1MMP8MMP3LMNA
SCHEMBL927527 0.82 FKBP1A (0.48) ALDH1A1NPSR1LMNASMN1; SMN2NPC1
SCHEMBL4840569 0.81 MMP8 (0.45) ALDH1A1NPSR1MMP8MMP3NPC1
SCHEMBL4844597 0.81 MMP8 (0.44) ALDH1A1NPSR1MMP8MMP3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD ALDH1A1 2845/4885NPSR1 297/4885MMP8 4719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.